Trial Search Results

THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation CONTINUED ACCESS

This is a prospective, multicenter, non-randomized continued access clinical evaluation utilizing the THERMOCOOL® SMARTTOUCH™ catheter.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Biosense Webster, Inc.

Stanford Investigator(s):


  • Device: THERMOCOOL® SMARTTOUCH™ Catheter


Phase 3


Inclusion Criteria:

   - Have had at least 3 atrial fibrillation episodes within 6 months of this study

   - Have failed at least one antiarrhythmic drug shown by repeated atrial fibrillation

   - 18 years of age or older

Exclusion Criteria including, but not limited to:

   - Have had previous ablation for atrial fibrillation

   - Have take amiodarone within 6 months of this study

   - Have had any heart surgery within the last 60 days

   - Have had a heart attack within the last 60 days

   - Females who are pregnant or breast feeding

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Paul Zei
Not Recruiting